Literature DB >> 8033378

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

A Y Finlay1, G K Khan.   

Abstract

A simple practical questionnaire technique for routine clinical use, the Dermatology Life Quality Index (DLQI) is described. One hundred and twenty patients with different skin diseases were asked about the impact of their disease and its treatment on their lives; a questionnaire, the DLQI, was developed based on their answers. The DLQI was then completed by 200 consecutive new patients attending a dermatology clinic. This study confirmed that atopic eczema, psoriasis and generalized pruritus have a greater impact on quality of life than acne, basal cell carcinomas and viral warts. The DLQI was also completed by 100 healthy volunteers; their mean score was very low (1.6%, s.d. 3.5) compared with the mean score for the dermatology patients (24.2%, s.d. 20.9). The reliability of the DLQI was examined in 53 patients using a 1 week test-retest method and reliability was found to be high (gamma s = 0.99).

Entities:  

Mesh:

Year:  1994        PMID: 8033378     DOI: 10.1111/j.1365-2230.1994.tb01167.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  813 in total

1.  A cost consequence study of the impact of a dermatology-trained practice nurse on the quality of life of primary care patients with eczema and psoriasis.

Authors:  D Kernick; A Cox; R Powell; D Reinhold; J Sawkins; A Warin
Journal:  Br J Gen Pract       Date:  2000-07       Impact factor: 5.386

2.  A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.

Authors:  A G de Tiedra; J Mercadal; X Badía; J M Mascaró; R Lozano
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

3.  CIS-based registration of quality of life in a single source approach.

Authors:  Fleur Fritz; Sonja Ständer; Bernhard Breil; Markus Riek; Martin Dugas
Journal:  BMC Med Inform Decis Mak       Date:  2011-04-21       Impact factor: 2.796

4.  [Dermato-epidemiology].

Authors:  C J Apfelbacher; T L Diepgen; E Weisshaar
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

5.  [Focal hyperhidrosis.Quality of life, socioeconomic importance and use of internal medicinal therapy].

Authors:  B Rzany; C Müller; M Hund
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

6.  Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands.

Authors:  I Lenoir-Wijnkoop; W M C van Aalderen; G Boehm; D Klaassen; A B Sprikkelman; M J C Nuijten
Journal:  Eur J Health Econ       Date:  2010-12-17

7.  Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05.

Authors:  Joseph F Fowler; James Q Del Rosso; Refika I Pakunlu; Srinivas Sidgiddi
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

8.  Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.

Authors:  Dylan Haynes; Jennifer L Strunck; Christina A Topham; Alex G Ortega-Loayza; Gail Kent; Pamela B Cassidy; Ronghua Hu; Keith Choate; Zhiping Wang; Yuangang Liu; Teri M Greiling
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282

9.  Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Authors:  Maddalena Napolitano; Luisa Costa; Francesco Caso; Matteo Megna; Raffaele Scarpa; Nicola Balato; Fabio Ayala; Anna Balato
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

10.  Cognitive, behavioral, and physiological reactivity to chronic itching: analogies to chronic pain.

Authors:  Lisette Verhoeven; Floris Kraaimaat; Piet Duller; Peter van de Kerkhof; Andrea Evers
Journal:  Int J Behav Med       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.